Zusammenfassung
Die peritoneale Tumoraussaat gastrointestinaler Tumoren stellt nach wie vor den wesentlichsten prognoselimitierenden Faktor dar. Trotz kurativer R0-Resektionen kommt es bei einem nicht unbeträchtlichen Anteil der Patienten zu einem peritonealen Rezidiv. Die additive hypertherme intraperitoneale Chemotherapie nach kurativer Resektion eines gastrointestinalen Karzinoms hat theoretisch das Potenzial, zur Verhinderung lokaler und peritonealer Rezidive bei akzeptabler Morbidität und Mortalität beizutragen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Baratti D, Kusamura S, Deraco M (2014) Prevention and Early Treatment of Peritoneal Metastases from Colorectal Cancer: Second-Look Laparotomy or Prophylactic HIPEC? J Surg Oncol 109: 225–226
Coccolini F, Catena F, Glehen O, et al. (2016) Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis. Eur J Surg Oncol 42: 1261–1267
Elias D, Goéré D, Di Pietrantonio D, et al. (2008) Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 247: 445–450
Glehen O, Schreiber V, Cotte, et al. (2004) Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 139: 20–26
Glehen O, Gilly FN, Arvieux C, et al. (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17: 2370–2377
Glehen O, Passot G, Villeneuve L, et al. (2014) GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer 14: 183
Graziosi L, Cantarella F, Mingrone E, et al. (2013) Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer. Ann Ital Chir 84: 551–556
Hioki M, Gotohoda N, Konishi M, et al. (2010) Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis. World J Surg 34: 555–562
Kang LY, Mok KT, Liu SI, et al. (2012) Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion. JCMA 76: 425–431
Kuramoto M, Shimada S, Ikeshima S, et al. (2009) Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg 250: 242–246
Sabbatini P, Aghajanian M, Leitao, et al. (2004) Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II trial. Clin Cancer Res 10: 2962–2967
Saladino E, Fleres F, Mazzeo C, et al. (2014) The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer. Anticancer Res 34: 2019–2022
Sammartino P, Sibio S, Biacchi D, et al. (2012) Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC. Gastroenterol Res Pract: 141585
Sugarbaker PH (2014) Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer. World J Gastroenterol 20: 9286–9291
Sugarbaker PH, Stuart A, Bijelic L (2011) Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer: Rationale and Report of Early Data. Int J Surg Oncol 2011: 161862
Tentes AAK, Kyziridis D, Kakolyris S, et al. (2012) Preliminary Results of Hyperthermic Intraperitoneal Intraoperative Chemotherapy as an Adjuvant in Resectable Pancreatic Cancer. Gastroenterol Res Pract: 506571
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Horvath, P., Beckert, S., Struller, F., Königsrainer, A., Königsrainer, I. (2018). Stellenwert der intraperitonealen Chemotherapie als Prophylaxe nach kurativer Resektion eines gastrointestinalen Karzinoms. In: Rau, B., Piso, P., Königsrainer, A. (eds) Peritoneale Tumoren und Metastasen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54500-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-662-54500-3_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-54499-0
Online ISBN: 978-3-662-54500-3
eBook Packages: Medicine (German Language)